Related by context. All words. (Click for frequent words.) 66 International Normalized Ratio 61 postoperative mortality 60 HbA1C levels 59 rFSH 59 TMP SMX 59 bezafibrate 59 ICD implants 58 timepoints 58 ARB telmisartan 58 IXEMPRA 58 idraparinux 58 HbA 1c levels 58 corticosteroid dose 58 NNT = 58 acetaminophen codeine 58 definite stent thrombosis 58 dose dabigatran 58 salmeterol fluticasone 57 placebo dexamethasone 57 neutrophil counts 57 recurrent VTE 57 PRADAXA #mg 57 arterial thromboembolic events 57 million1 representing 57 nonvertebral fractures 57 relapsed MM 57 elevated LDH 57 postoperative morbidity 57 PASI scores 57 #.# Crores [003] 57 BSIs 57 imipenem 57 lipid lowering medication 57 anticoagulant warfarin 57 octreotide LAR 57 p = #.# [003] 57 TEAEs 57 Hb A1C 57 nadolol 57 ticlopidine 57 nonfatal myocardial infarction MI 57 oral anticoagulation 57 albumin excretion 56 dalteparin 56 angiographic restenosis 56 glycated hemoglobin levels 56 atorvastatin #mg 56 ug kg 56 serum PTH 56 reinfarction 56 Aloxi injection 56 intracerebral hemorrhages 56 Neulasta ® 56 mg simvastatin 56 coronary revascularization procedures 56 CsA 56 COPD exacerbation 56 pyrimethamine 56 baseline LDH 56 divalproex sodium 56 FluCAM arm 56 colorectal adenoma 56 detemir 56 piperacillin tazobactam 56 certolizumab 56 hypoglycemic events 56 patients undergoing CABG 56 antithrombotics 55 mIU ml 55 hemoglobin A1c levels 55 prolonged QT interval 55 inflammatory biomarkers 55 serum urate 55 hemorrhagic complications 55 myocardial infarctions MIs 55 poor metabolizers 55 aldosterone antagonist 55 ALTACE 55 #.# crores [001] 55 oral prednisolone 55 haemorrhagic stroke 55 PSA nadir 55 TURBT 55 9M FY# [002] 55 inhospital 55 salmeterol fluticasone propionate 55 cGy 55 DBFOT pattern 55 acute respiratory tract infections 55 Postoperative complications 55 p = NS 55 noncardiac 55 #.# Crores [001] 55 milliliters mL 55 MIC# [001] 55 oxycodone CR 55 foveal thickness 55 mcg albinterferon alfa 2b 55 oral diclofenac 55 nonvertebral fracture 55 acarbose 55 MoxDuo TM IR 55 transaminase levels 55 death reinfarction 55 serum aminotransferase levels 55 oral hypoglycemic agents 55 triglyceride concentration 55 Homocysteine levels 55 RISPERDAL ® 54 darbepoetin alfa 54 flutamide 54 lumiracoxib 54 dosing frequency 54 leucopenia 54 #.#/#.# mmHg [001] 54 ritonavir boosted 54 metformin hydrochloride 54 macrolide antibiotic 54 pulmonary dysfunction 54 glulisine 54 adiponectin concentrations 54 A1c levels 54 concomitant AEDs 54 antiandrogen 54 coronary artery bypass grafts 54 Kogenate ® FS 54 de aths 54 endometrial thickness 54 HBeAg seroconversion 54 serum sodium levels 54 imiquimod cream 54 APTIVUS r 54 CAELYX 54 postoperative complication 54 hepatorenal syndrome 54 bovine thrombin 54 virologic breakthrough 54 crores Rs. 54 CHD mortality 54 inhospital mortality 54 symptomatic intracranial 54 IPAH 54 perioperative mortality 54 dose Iluvien 54 fluoxetine paroxetine 54 Lantus insulin 54 #mg capsules [001] 54 moderately emetogenic 54 serum phosphate 54 oxcarbazepine 54 analgesic medications 54 β blockers 54 serum potassium levels 54 rizatriptan 54 #.#-#.# [011] 54 incontinence episodes 54 oral antidiabetic 54 revascularization procedures 54 ACTOS ® 54 Complication rates 54 epoetin alfa 54 triacylglycerol concentrations 54 serum lipid levels 54 gastrointestinal bleeds 54 thromboprophylaxis 54 recurrent venous thromboembolism 54 metabolic parameters 54 concomitant medications 54 Benazepril 54 CI #.#-#.# [001] 54 alanine aminotransferase ALT 54 bolus dose 54 loop diuretics 54 Dosages 54 ACE Inhibitor 54 ethambutol 54 Indian Rupees 54 lumbar spine BMD 54 #mg q8h 54 #,#,# crores 54 FXIII 54 urinary albumin excretion 53 PSADT 53 dosage regimens 53 neurologic complications 53 metoprolol tartrate 53 MADRS score 53 intravitreal injections 53 EXJADE 53 mCi m 2 53 lung resections 53 acromegalic patients 53 cerebrovascular events 53 oral antidiabetic drugs 53 symptomatic VTE 53 pneumococcal carriage 53 serum triglyceride levels 53 MMSE scores 53 LS BMD 53 Alkeran 53 Pfizer Norvasc 53 polytherapy 53 μg kg 53 Preterm infants 53 trimethoprim 53 elevated triglyceride levels 53 mcg doses 53 Mestinon 53 Filgrastim 53 glycosylated hemoglobin levels 53 cobalamin 53 atazanavir ritonavir 53 AUC0 #hr 53 estimated GFR 53 noncardiovascular mortality 53 hemodialysis patients 53 platelet reactivity 53 gliclazide 53 inhaled budesonide 53 urate lowering therapy 53 #.#mL 53 XOPENEX Inhalation Solution 53 TPV r 53 coronary stenosis 53 CABG surgeries 53 tipranavir r 53 Hydrochlorothiazide 53 postintervention 53 plasma cortisol 53 alteplase 53 prioryear 53 9M FY 53 Clindamycin 53 PDP MLR 53 CVD mortality 53 % CI #.#-#.# [008] 53 mU liter 53 HbA1c levels 53 daily subcutaneous injections 53 CPAP adherence 53 Tumors shrank 53 Elitek 53 odds ratios ORs 53 anagrelide 53 macrovascular events 53 RE LY ® 53 ketorolac 53 serum calcium levels 53 symptomatic intracranial hemorrhage 53 non valvular atrial 53 symptomatic hyponatremia 53 serum bicarbonate 53 pamidronate 53 PBDIT 53 lipid lowering medications 53 glyburide 53 NIHSS score 53 KADIAN ® 53 streptokinase 53 LUMIGAN ® 53 prothrombin 53 NSTEMI 53 LUMIGAN R 53 conventional antipsychotics 53 intra abdominal abscess 53 recombinant FSH 53 ABC/3TC 53 warfarin 53 diverticular bleeding 53 mg BID dose 53 TDF FTC 53 SCr 53 ALT flares 53 cholestyramine 53 creatinine ratio 53 Pharmacokinetic parameters 53 periprocedural 52 calculated creatinine clearance 52 insulin detemir 52 inpatient hospitalizations 52 diastolic pressures 52 Hycamtin ® 52 oral antidiabetes 52 #mg tablet [002] 52 IFN alfa 52 prevalences 52 #mg capsules [002] 52 infrequent dosing 52 extrapyramidal symptoms 52 leukocyte count 52 Danazol 52 amphotericin B 52 cephalosporin antibiotic 52 Hazard Ratio = 52 rebleeding 52 ALT elevation 52 #mg doses [002] 52 overt nephropathy 52 NovoLog ® Mix 52 oral allopurinol 52 oral hypoglycemic 52 Kivexa 52 sulfamethoxazole 52 VTE prophylaxis 52 symptomatic hypoglycemia 52 Peg IFN 52 beta lactam antibiotic 52 clozapine Clozaril 52 adenoma recurrence 52 LATUDA 52 coronary revascularizations 52 Poisson regression 52 Dabur Pharma Ltd. 52 receiving ISENTRESS 52 hematological parameters 52 hepatic enzymes 52 zoledronate 52 Keep stoploss 52 Viread Emtriva 52 levalbuterol 52 lactate dehydrogenase 52 coronary interventions 52 postprocedure 52 retrospective cohort 52 loperamide 52 sulfonamide 52 x ULN 52 Febrile neutropenia 52 adjunctive placebo 52 #mg/day [002] 52 Kaplan Meier estimates 52 simvastatin #mg 52 HbA 1C 52 serum HCV RNA 52 EBDITA 52 confidence intervals CIs 52 posttransplant 52 QALE 52 torsade de pointes 52 Epoetin alfa 52 upper gastrointestinal bleeding 52 spine fusions 52 chlorambucil 52 serum cortisol 52 concentration Cmax 52 inotropes 52 cefazolin 52 DLQI 52 Platelet counts 52 #x FY#E earnings [002] 52 venous thromboembolisms 52 SPRIX ® 52 nonfatal MI 52 AstraZeneca Toprol XL 52 Bicillin LA 52 labetalol 52 Mn USD 52 sustained ventricular tachycardia 52 oral ribavirin 52 hyperglycaemia 52 Glimepiride 52 endoscopic remission 52 sevelamer 52 intravenous dosing 52 postoperative pulmonary 52 -#.# log# 52 IIIa inhibitors 52 nonfatal cardiovascular 52 nonmelanoma skin cancers 52 micafungin 52 vitamin D3 cholecalciferol 52 EDSS score 52 thrombotic events 52 serum lipid 52 microg 52 GnRH agonist 51 systemic corticosteroids 51 Natalizumab 51 acute myocardial infarctions 51 creatine kinase MB 51 peak VO2 51 glycated hemoglobin HbA1c 51 μmol L 51 underwent CABG 51 RLAI 51 interferon injections 51 serum homocysteine 51 hemoglobin Hb 51 electrical cardioversion 51 HBeAg + 51 Androgel R 51 mcg kg min 51 spontaneous bowel movements 51 generic risperidone 51 rosiglitazone maleate 51 REMINYL ® 51 primaquine 51 hemagglutination inhibition 51 Thrombin 51 HOMA IR 51 Ganciclovir 51 tapentadol ER 51 PBIDT 51 postoperative infections 51 Erythropoietic therapies may 51 acid suppressive medication 51 inhaled glucocorticoids 51 Intracerebral hemorrhage 51 Hb levels 51 Besylate 51 MMSE score 51 μg d 51 Intravenous immunoglobulin 51 fibrinolysis 51 Epirubicin 51 haloperidol Haldol 51 dose regimens 51 del 5q MDS 51 protease inhibitors PIs 51 genotypic resistance 51 fludrocortisone 51 Sporanox 51 Plavix clopidogrel 51 pegfilgrastim 51 #bp QoQ 51 acute rhinosinusitis 51 Mg Uk 51 Stent thrombosis 51 Rs #,#,# Rs #,#,# 51 conjugated estrogens 51 FOSRENOL ® 51 PROCRIT ® 51 ug dose 51 DAS# scores 51 anticoagulation therapy 51 androgen blockade 51 doxorubicin cyclophosphamide 51 galiximab 51 echocardiographic parameters 51 postoperative chemotherapy 51 myocardial infarctions 51 WinRho 51 empyema 51 pegylated interferon alfa 51 ADEs 51 serum concentrations 51 plasma creatinine 51 % Confidence Interval 51 oral olanzapine 51 Ischemic strokes 51 coronary revascularization 51 CK # plasma concentrations 51 interferon alfa 2b 51 UPDRS scores 51 intensive statin therapy 51 regression coefficient 51 racemic albuterol 51 Hazard Ratio 51 Epivir HBV 51 Antipsychotic medications 51 NovoSeven ® 51 Seroquel quetiapine fumarate 51 dipyridamole 51 μg mL 51 Daptomycin 51 psychiatric comorbidities 51 Mycophenolate mofetil 51 #.#cr [004] 51 Metoprolol 51 RVUs 51 vaccinees 51 antiseptic chlorhexidine 51 Triglyceride levels 51 thrombocytopenic patients 51 aminotransferase elevations greater 51 CI -#.# 51 PegIFN RBV 51 aminocaproic acid 51 μg liter 51 Creatinine 51 BYETTA exenatide injection 51 Hypotension 51 ORG IMS 51 QTcF 51 Rs.#.# crore [002] 51 proton MR spectroscopy 51 fatal myocardial infarction 51 cefotaxime 51 antiarrhythmic drug 51 dosing intervals 51 plasma glucose 51 intracerebral haemorrhage 51 dose cohort 51 sotalol 51 nocturnal hypoglycaemia 51 acid reducer 51 seropositivity 51 extracolonic findings 51 Megace ES 51 hetastarch 51 solifenacin 51 Stomach stapling 51 postoperative AF 51 ganciclovir 51 Meloxicam 51 femoral shaft fracture 51 C diff infections 51 ADCS ADL 51 AZT zidovudine Retrovir 51 severe exacerbations 51 vasopressor 51 Rs.#.# cr [002] 51 dysmenorrhoea 51 HAART regimen 51 OGTT 51 Sinemet 51 cystoscopic 51 ziprasidone 51 nonobstructive CAD 51 acute gout flares 51 Rs.#.# [005] 51 Wanbury 51 tinidazole 51 repaglinide 51 ATACAND 51 Double Blind Randomized 51 microbiological eradication 51 postdischarge 51 preoperative radiotherapy 51 dysglycemia 51 virological response 51 Venlafaxine 51 Crohn Disease Activity 50 UPPP 50 poliovirus vaccine 50 nitroprusside 50 THROMBIN JMI ® 50 Severe hypoglycemia 50 colorectal cancer incidence 50 neurodevelopmental impairment 50 Score DAS# 50 affective psychosis 50 carotid IMT 50 pretreatment baseline 50 atherothrombotic disease 50 macrolide antibiotics 50 INVEGA ® 50 Fasting plasma glucose 50 SpO 2 50 #mg/#mg 50 #x FY#E earnings [001] 50 IFN α 50 Heparins 50 pulmonary embolism PE 50 preoperative PSA 50 CHD CVD 50 ng dL 50 recurrent UTI 50 gastric pH 50 SMZ TMP 50 #.# crores [003] 50 severe asthma exacerbations 50 fluticasone salmeterol 50 tertiles 50 undetectable HBV DNA 50 morbidity mortality 50 gatifloxacin 50 Subgroup analyzes 50 hepatitis B immune globulin 50 Rs#mn [001] 50 Erlotinib 50 deep venous thromboses 50 antidepressant pharmacotherapy 50 URTI 50 lactulose 50 mL/min/#.# m2 50 mg QD 50 AGHD 50 TMC# r 50 mequinol 50 Rs .#,# 50 acetazolamide 50 serologic testing 50 atypical antipsychotic drugs 50 Pancreatic neuroendocrine tumors 50 venous blood clots 50 acetaminophen ibuprofen 50 nanomolar 50 C. difficile colitis 50 biguanide 50 gets USFDA nod 50 Precose 50 nonsevere 50 severe neutropenia 50 postoperative infection 50 #.# crore [002] 50 fragility fracture 50 mg/# mL [002] 50 antiepileptic medications 50 NATRECOR ® 50 MS DRGs 50 diarrheal deaths 50 rituximab Rituxan ® 50 EDSS scores 50 droperidol 50 Arixtra ® 50 pmol L 50 immunosuppressives 50 acute myocardial infarction MI 50 multivariable adjustment 50 iodixanol 50 SSRI SNRI 50 pharmacodynamic parameters 50 liver transplantations 50 vitamin D2 50 SHBG levels 50 Hydrochloride Injection 50 plasma glucose levels 50 maximally tolerated 50 NHAMCS 50 Keppra XR 50 mg eq 50 Nascobal 50 liver histology 50 antimuscarinic 50 TT genotype 50 glibenclamide 50 mcL 50 topical ocular 50 incidence ≥ 50 postprandial blood glucose 50 liver transplant recipients 50 insulin glulisine 50 Nystatin 50 9M FY# [001] 50 TOPAMAX ® 50 paroxetine sertraline 50 bendamustine 50 Wellbutrin XL R 50 timolol maleate 50 #.#mg dose 50 narcotic analgesics 50 cefdinir 50 oncologic outcomes 50 maximal doses 50 MS DRG 50 potassium supplementation 50 hemoglobin concentrations 50 necrotizing pancreatitis 50 anthracycline chemotherapy 50 Cardiopulmonary bypass 50 MMX mesalamine 50 CHADS2 50 hypopneas 50 Erythromycin 50 thromboembolic 50 ug ml 50 statin cholesterol lowering 50 CLL SLL 50 Exenatide Byetta 50 treat NNT 50 Cotrimoxazole 50 DAPT 50 anastomotic leak 50 #/#mg 50 Rifampin 50 Rs.5 crores 50 ceftazidime 50 antihypertensive medications 50 LV ejection fraction 50 Fx adj 50 repeat revascularization 50 globulin 50 Privigen 50 intravenous immunoglobulin IVIG 50 hydrochloride capsules 50 Maternal Mortality Ratio 50 systolic dysfunction 50 Tasigna prolongs 50 follitropin beta 50 MoxDuo IR 50 9mg 50 INR 50 Neulasta pegfilgrastim 50 ischemic cardiovascular 50 glyceryl trinitrate 50 CCyR 50 non aspirin NSAIDs 50 virologic failure 50 metformin XR 50 total thyroidectomy 50 mg/m2 dose 50 revascularizations 50 antiangiogenic agents 50 postoperative complications 50 chemotherapeutic regimen 50 fatal hemorrhagic 50 IBDQ 50 ug mL 50 tylosin 50 intramuscular dose 50 terfenadine 50 pulmonary exacerbations 50 CI #.#-#.# p = 50 quinapril 50 CYPHER Stent 50 CDI recurrence 50 neurocognitive outcomes 49 bacteremia 49 mean baseline A1C 49 fetal malformations 49 tumor histology 49 neurologic sequelae 49 tazobactam 49 mmHg p = 49 subcutaneous dose 49 oligohydramnios 49 laboratory abnormalities 49 MIRP 49 #.#x FY#E EPS [001] 49 iodinated contrast 49 quetiapine 49 mg orally 49 hyoscyamine 49 oocytes retrieved 49 Rs.#.# cr [003] 49 AST ALT 49 pCR 49 apnea hypopnea 49 CMV infection 49 magnesium intake 49 onset atrial fibrillation 49 Camptosar ® 49 hypoglycaemic episodes 49 invasive aspergillosis 49 invasive Hib 49 VT VF 49 mg/m2/day 49 injected subcutaneously 49 endometrial carcinoma 49 chronic rhinosinusitis 49 nevirapine regimen 49 glycemia 49 Ampicillin 49 H1 FY 49 venous thromboembolic disease 49 bariatric surgeries performed 49 -#.# ± [002] 49 Captopril 49 #bps qoq [001] 49 intravenous diuretics 49 antipsychotic prescribing 49 Caesarean deliveries 49 IRLS score 49 Re.#.# 49 PASI score 49 ml min 49 Zyprexa olanzapine 49 Q4 FY'# 49 cardioembolic stroke 49 intravenous heparin 49 angiotensin receptor blockers ARB 49 hysterectomies performed 49 tipranavir 49 #mg/m# [001] 49 Torsades de Pointes 49 Leflunomide 49 RONW 49 preintervention 49 physiologic parameters 49 Rs.# Crores [001] 49 KADIAN R 49 Tindamax 49 nonadherence 49 mg kg dose 49 tramadol HCl 49 antihypertensive medication 49 comorbid conditions 49 C. diff infections 49 ergotamine 49 Felodipine 49 microlitre 49 #,#,#,# equity [002] 49 apolipoprotein B 49 intravenous IV infusion 49 dimeglumine 49 Biaxin clarithromycin 49 Rs.# # 49 Bonferroni correction 49 ICDs implanted 49 Cyklokapron 49 piperacillin 49 q#d 49 Prilosec omeprazole 49 Losartan Potassium 49 androgen suppression 49 susceptible isolates 49 hyperalgesia 49 neurodevelopmental outcome 49 AUC0 49 Dacogen decitabine 49 acetaminophen poisoning 49 intravenous vancomycin 49 cecal intubation 49 conditional logistic regression 49 generic simvastatin 49 intravenous cyclophosphamide 49 Hematocrit 49 HAM D# scores 49 EURIDIS 49 ulcerative proctitis 49 #.#x FY#E EV EBITDA [002] 49 MIRAPEX 49 Tumor Response 49 cidofovir 49 #ug [002] 49 ipsilateral stroke 49 Levothyroxine 49 mm ³ 49 #IU [001] 49 TTM EPS 49 estimated glomerular filtration 49 alexandrite laser 49 micromolar 49 ml vial 49 #mg/kg [001] 49 REYATAZ R 49 neuropsychiatric symptoms 49 Skin sterol 49 HCCs 49 ASD prevalence 49 recurrent tonsillitis 49 asthma exacerbation 49 Digoxin 49 Ferrellgas annualized 49 ceftriaxone 49 discontinuations 49 F FDG PET 49 per qtl 49 maximal dose 49 corticosteroid therapy 49 #.#x FY#E BV 49 logistic regression analysis 49 severe hypoglycemic 49 acid suppressive medications 49 Anu Labs 49 beta blockers ACE inhibitors 49 neonatal morbidity 49 Terbinafine 49 mg qd 49 Rs.5 ,# 49 Coronary stent 49 Cefixime 49 thyroglobulin 49 severe rotavirus gastroenteritis 49 coxib 49 Increlex R 49 QT interval prolongation 49 NHANES III 49 Venous thromboembolism 49 MDRD 49 dosing interval 49 atypical antipsychotic medications 49 Zocor simvastatin 49 prescribed statins 49 nalbuphine 49 decompensated heart failure 49 ug g 49 posttreatment 49 PaO 2 49 Index CDAI 49 coinfected patients 49 events ADEs 49 INR#.# [006] 49 Estrostep 49 evaluable subjects 48 RSV infections 48 Leucovorin 48 boosted atazanavir 48 milligram mg 48 Orchid Chem 48 BVPS 48 JPY#.# [005] 48 #x FY#E EPS [001] 48 Rs.#.# Cr [001] 48 Cariprazine 48 HPA axis suppression 48 hyperbilirubinemia 48 #crore [001] 48 salmeterol HFA MDI 48 microtubule inhibitor 48 N acetylcysteine 48 Budesonide 48 bolus injection 48 Rs #,#-# [001] 48 SoloSTAR ® 48 Bicillin CR 48 EuroSCORE 48 griseofulvin 48 ofpatients 48 Rs.#mn 48 reoperations 48 nonfasting 48 Clostridium difficile infections 48 postoperative hemorrhage 48 Rifampicin 48 hypericin 48 ketorolac tromethamine 48 timepoint 48 eflornithine 48 beta blocker metoprolol 48 undetectable viral 48 acting insulin analogues 48 #.#x FY#E earnings [002] 48 Angiomax bivalirudin 48 COPD exacerbations 48 INR2 48 uM 48 ancrod 48 telaprevir dosed 48 Rs#.# crore [003] 48 herpes zoster shingles 48 mmol kg 48 Bloodstream infections 48 Rs.#/quintal 48 % CI #.#-#.# [001] 48 guideline concordant 48 recurrent ischemia 48 NSAID diclofenac 48 INR6 48 Treatment emergent adverse 48 CDAI 48 #mg #mg #mg [003] 48 Rs.#.# lakhs [004] 48 mm3 48 Rs.# crore Rs.1 48 Rs.3 ,# 48 variceal bleeding 48 telaprevir dosing 48 hypertension diabetes mellitus 48 HIV HCV coinfected 48 tizanidine 48 nmol 48 dose titration 48 mometasone 48 Amgen Sensipar 48 wef #.#.# [002] 48 MBq 48 Adjusted EBITA 48 nonmedically 48 varicella infection 48 resolves spontaneously 48 #.# crore [003] 48 unbranded generics 48 Ipca Laboratories 48 Insulin Delivery Systems 48 4mg/kg 48 Kaletra lopinavir ritonavir 48 darunavir ritonavir 48 Fanapt iloperidone 48 events SAEs 48 ranitidine 48 transurethral 48 mg q8h 48 Chola DBS 48 Ann Intern Med 48 Trimethoprim 48 postinjury 48 genes CYP#C# 48 balsalazide 48 blood glucose concentrations 48 Paroxetine 48 Rs4 lakh 48 Listeria infections 48 ischemic complications 48 lacosamide 48 polymyxin B 48 Baseline characteristics 48 sq cm 48 INR#.# billion [001] 48 CRIXIVAN 48 HAQ DI 48 Orally administered 48 System IPSS 48 bps qoq 48 peak plasma concentrations 48 Methylprednisolone 48 tumor regressions 48 Urinary tract infection 48 calcipotriol 48 related hematological toxicity 48 filgrastim 48 granisetron 48 Decadron 48 carbohydrate oxidation 48 fibrin sealants 48 androgen deprivation 48 gonadotropins 48 newer atypical antipsychotics